Overview

Japanese Bridging Study Conducted in the United States

Status:
Withdrawn
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics following single oral and multiple oral doses BMS-791325 in healthy Japanese subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb